155 related articles for article (PubMed ID: 37380798)
1. Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case series.
Yamanaka T; Takemura K; Hayashida M; Suyama K; Urakami S; Miura Y
Cancer Chemother Pharmacol; 2023 Sep; 92(3):235-240. PubMed ID: 37380798
[TBL] [Abstract][Full Text] [Related]
2. Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints.
Stump SE; Whang YE; Crona DJ
Invest New Drugs; 2018 Dec; 36(6):1143-1146. PubMed ID: 29956055
[TBL] [Abstract][Full Text] [Related]
3. [Visits of patients with exertional rhabdomyolysis to the Emergency Department at Landspítali, The National University Hospital of Iceland in the years 2008-2012].
Halldorsson AB; Benedikz E; Olafsson I; Mogensen B
Laeknabladid; 2016 Mar; 102(3):131-5. PubMed ID: 26985591
[TBL] [Abstract][Full Text] [Related]
4. Exertional rhabdomyolysis and causes of elevation of creatine kinase.
Bäcker HC; Busko M; Krause FG; Exadaktylos AK; Klukowska-Roetzler J; Deml MC
Phys Sportsmed; 2020 May; 48(2):179-185. PubMed ID: 31532694
[No Abstract] [Full Text] [Related]
5. Positioning injury, rhabdomyolysis, and serum creatine kinase-concentration course in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection.
Mattei A; Di Pierro GB; Rafeld V; Konrad C; Beutler J; Danuser H
J Endourol; 2013 Jan; 27(1):45-51. PubMed ID: 22770120
[TBL] [Abstract][Full Text] [Related]
6. The modern spectrum of rhabdomyolysis: drug toxicity revealed by creatine kinase screening.
Linares LA; Golomb BA; Jaojoco JA; Sikand H; Phillips PS
Curr Drug Saf; 2009 Sep; 4(3):181-7. PubMed ID: 19534642
[TBL] [Abstract][Full Text] [Related]
7. Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy.
Sidana A; Walton-Diaz A; Truong H; Siddiqui MM; Miao N; Shih J; Mannes A; Bratslavsky G; Linehan WM; Metwalli AR
Int Urol Nephrol; 2016 Jul; 48(7):1047-1053. PubMed ID: 27093966
[TBL] [Abstract][Full Text] [Related]
8. Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell Carcinoma.
Markham A
Target Oncol; 2022 Mar; 17(2):193-201. PubMed ID: 35175500
[TBL] [Abstract][Full Text] [Related]
9. Serum creatine kinase levels and renal function measures in exertional muscle damage.
Clarkson PM; Kearns AK; Rouzier P; Rubin R; Thompson PD
Med Sci Sports Exerc; 2006 Apr; 38(4):623-7. PubMed ID: 16679975
[TBL] [Abstract][Full Text] [Related]
10. Serum creatine kinase levels are not associated with an increased need for continuous renal replacement therapy in patients with acute kidney injury following rhabdomyolysis.
Xiao L; Ran X; Zhong Y; Le Y; Li S
Ren Fail; 2022 Dec; 44(1):893-901. PubMed ID: 35611437
[TBL] [Abstract][Full Text] [Related]
11. Marked elevation of serum creatine kinase associated with olanzapine therapy.
Marcus EL; Vass A; Zislin J
Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
[TBL] [Abstract][Full Text] [Related]
12. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.
Choueiri TK; Escudier B; Powles T; Tannir NM; Mainwaring PN; Rini BI; Hammers HJ; Donskov F; Roth BJ; Peltola K; Lee JL; Heng DYC; Schmidinger M; Agarwal N; Sternberg CN; McDermott DF; Aftab DT; Hessel C; Scheffold C; Schwab G; Hutson TE; Pal S; Motzer RJ;
Lancet Oncol; 2016 Jul; 17(7):917-927. PubMed ID: 27279544
[TBL] [Abstract][Full Text] [Related]
13. Determinants of elevated creatine kinase activity and creatine kinase MB-fraction following cardiopulmonary resuscitation.
Mattana J; Singhal PC
Chest; 1992 May; 101(5):1386-92. PubMed ID: 1582302
[TBL] [Abstract][Full Text] [Related]
14. Muscle toxicity with statins.
Hedenmalm K; Alvan G; Ohagen P; Dahl ML
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
[TBL] [Abstract][Full Text] [Related]
15. Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Loo Gan C; Huang J; Pan E; Xie W; Schmidt AL; Labaki C; Meza L; Bouchard G; Li H; Jackson-Spence F; Sánchez-Ruiz C; Powles T; Kumar SA; Weise N; Hall WA; Rose BS; Beuselinck B; Suarez C; Pal SK; Choueiri TK; Heng DYC; McKay RR
Eur Urol Oncol; 2023 Apr; 6(2):204-211. PubMed ID: 36328934
[TBL] [Abstract][Full Text] [Related]
16. Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.
Donskov F; Motzer RJ; Voog E; Hovey E; Grüllich C; Nott LM; Cuff K; Gil T; Jensen NV; Chevreau C; Negrier S; Depenbusch R; Bergmann L; Cornelio I; Champsaur A; Escudier B; Pal S; Powles T; Choueiri TK
Eur J Cancer; 2020 Feb; 126():1-10. PubMed ID: 31887537
[TBL] [Abstract][Full Text] [Related]
17. Extremely High Creatine Kinase Activity in Rhabdomyolysis without Acute Kidney Injury.
Hansrivijit P; Yarlagadda K; Puthenpura MM; Cunningham JM
Am J Case Rep; 2020 May; 21():e924347. PubMed ID: 32430491
[TBL] [Abstract][Full Text] [Related]
18. The value of serum creatine kinase in predicting the risk of rhabdomyolysis-induced acute kidney injury: a systematic review and meta-analysis.
Safari S; Yousefifard M; Hashemi B; Baratloo A; Forouzanfar MM; Rahmati F; Motamedi M; Najafi I
Clin Exp Nephrol; 2016 Apr; 20(2):153-61. PubMed ID: 26801932
[TBL] [Abstract][Full Text] [Related]
19. Relationship of creatine kinase elevation and acute kidney injury in pediatric trauma patients.
Talving P; Karamanos E; Skiada D; Lam L; Teixeira PG; Inaba K; Johnson J; Demetriades D
J Trauma Acute Care Surg; 2013 Mar; 74(3):912-6. PubMed ID: 23425757
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.
Waldman W; Kabata PM; Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Dargan PI; Sein Anand J
PLoS One; 2021; 16(3):e0246297. PubMed ID: 33705425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
